• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Myocardial Injury in COVID-19-Can We Successfully Target Inflammation?-Reply.

作者信息

Fan Yongzhen, Guo Tao, Lu Zhibing

机构信息

Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.

出版信息

JAMA Cardiol. 2020 Sep 1;5(9):1070-1071. doi: 10.1001/jamacardio.2020.2572.

DOI:10.1001/jamacardio.2020.2572
PMID:32936268
Abstract
摘要

相似文献

1
Myocardial Injury in COVID-19-Can We Successfully Target Inflammation?-Reply.新型冠状病毒肺炎中的心肌损伤——我们能否成功靶向炎症？——回复
JAMA Cardiol. 2020 Sep 1;5(9):1070-1071. doi: 10.1001/jamacardio.2020.2572.
2
Myocardial Injury in COVID-19-Can We Successfully Target Inflammation?新型冠状病毒肺炎中的心肌损伤——我们能否成功靶向炎症？
JAMA Cardiol. 2020 Sep 1;5(9):1069-1070. doi: 10.1001/jamacardio.2020.2569.
3
Letter: SARS-CoV-2 induced gastrointestinal inflammation-authors' reply.信件：SARS-CoV-2 诱导的胃肠道炎症——作者的回复。
Aliment Pharmacol Ther. 2020 Dec;52(11-12):1750-1751. doi: 10.1111/apt.16117.
4
Treatments for COVID-19: emerging drugs against the coronavirus - reply.新型冠状病毒肺炎的治疗方法：对抗冠状病毒的新型药物——回复
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.10108.
5
Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality.2019冠状病毒病（COVID-19）与心肌损伤及死亡率的关联
JAMA Cardiol. 2020 Jul 1;5(7):751-753. doi: 10.1001/jamacardio.2020.1105.
6
Implications for the Care of Patients With COVID-19 and Inflammatory Myocardial Disease-Reply.
JAMA Cardiol. 2020 Nov 1;5(11):1306-1307. doi: 10.1001/jamacardio.2020.3392.
7
Reply Letter - COVID-19 (Novel Coronavirus 2019) - Recent trends.回复信 - 2019冠状病毒病（新型冠状病毒2019） - 近期趋势
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6482-6483. doi: 10.26355/eurrev_202006_21629.
8
REPLY TO: Interleukin-17: a potential therapeutic target in COVID-19.回复：白细胞介素-17：新冠病毒病的一个潜在治疗靶点。
J Infect. 2020 Sep;81(3):e37-e38. doi: 10.1016/j.jinf.2020.06.063. Epub 2020 Jun 29.
9
Reply to "Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care".对《2019冠状病毒病（COVID-19）：对临床牙科护理的影响》的回复
J Endod. 2020 Sep;46(9):1342. doi: 10.1016/j.joen.2020.08.005. Epub 2020 Aug 15.
10
Myocardial Injury in COVID-19 Patients: The Beginning or the End?新冠病毒肺炎患者的心肌损伤：是开端还是结局？
J Am Coll Cardiol. 2020 Aug 4;76(5):547-549. doi: 10.1016/j.jacc.2020.06.045.

引用本文的文献

1
COVID-19 ARDS in two patients with left ventricular assist device.两名左心室辅助装置患者的 COVID-19 急性呼吸窘迫综合征。
J Artif Organs. 2022 Jun;25(2):148-154. doi: 10.1007/s10047-021-01288-y. Epub 2021 Aug 1.
2
Coronary artery calcification and epicardial adipose tissue as independent predictors of mortality in COVID-19.冠状动脉钙化和心外膜脂肪组织是 COVID-19 患者死亡的独立预测因子。
Int J Cardiovasc Imaging. 2021 Oct;37(10):3093-3100. doi: 10.1007/s10554-021-02276-2. Epub 2021 May 12.
3
Supplementary Therapeutic Possibilities to Alleviate Myocardial Damage Due to Microvascular Dysfunction in Coronavirus Disease 2019 (COVID-19).
缓解2019冠状病毒病（COVID-19）微血管功能障碍所致心肌损伤的补充治疗可能性
Cardiol Ther. 2021 Jun;10(1):1-7. doi: 10.1007/s40119-021-00216-8. Epub 2021 Apr 2.
4
Contemporary use of cardiac imaging for COVID-19 patients: a three center experience defining a potential role for cardiac MRI.新冠病毒肺炎患者心脏成像的当代应用：一项三中心经验，确定心脏磁共振成像的潜在作用
Int J Cardiovasc Imaging. 2021 May;37(5):1721-1733. doi: 10.1007/s10554-020-02139-2. Epub 2021 Feb 9.
5
Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis.间充质干细胞衍生的细胞外囊泡携带 miRNA 作为 COVID-19 的潜在多靶点治疗方法：一项计算机分析。
Stem Cell Rev Rep. 2021 Apr;17(2):341-356. doi: 10.1007/s12015-021-10122-0. Epub 2021 Jan 28.
6
Predictors of mortality of COVID-19 in the general population and nursing homes.一般人群和养老院中 COVID-19 死亡率的预测因素。
Intern Emerg Med. 2021 Sep;16(6):1487-1496. doi: 10.1007/s11739-020-02594-8. Epub 2021 Jan 5.
7
Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic.新型冠状病毒肺炎大流行期间急性冠状动脉综合征患者的临床特征。
J Thromb Thrombolysis. 2021 Jul;52(1):95-104. doi: 10.1007/s11239-020-02340-z. Epub 2020 Nov 16.
8
The effect of favipiravir on QTc interval in patients hospitalized with coronavirus disease 2019.法匹拉韦对2019冠状病毒病住院患者QTc间期的影响。
J Electrocardiol. 2020 Nov-Dec;63:115-119. doi: 10.1016/j.jelectrocard.2020.10.015. Epub 2020 Nov 6.